companydata.dkcompanydata.dk

SERA-SCANDIA A/S: Financial statements 2021

CVR: 14605185

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 242,301,000 and a net result of DKK 16,081,000 compared with DKK -16,558,000 the year before. That is an increase of 6,478.9% compared with the year before. The profit margin was 6.6%. Equity in the 2021 report amounted to DKK 62,020,000. The solvency ratio was 26.8%. The company had 176 employees in the financial year.

Revenue
DKK 242,301,000
Gross Profit
DKK 28,715,000
Profit/Loss
DKK 16,081,000
Equity
DKK 62,020,000
Total Assets
DKK 231,516,000
Employees
176

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021242.3M28.7M16.1M62M176
20203.7M433K-16.6M50.3M186
20192.7M683K-9.9M66.9M207
20182.7M345K23.4M63.2M220
20172.8M1.3M8M39.9M190

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like SERA-SCANDIA A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Jørn Martin Bank joins the board of SERA-SCANDIA A/SDec 17, 2021

As of December 17, 2021, Jørn Martin Bank has joined the board of directors of SERA-SCANDIA A/S.

Jørn Martin Bank leaves the board of SERA-SCANDIA A/SDec 16, 2021

As of December 16, 2021, Jørn Martin Bank has left the board of directors of SERA-SCANDIA A/S.

SERA-SCANDIA A/S: The 2020 annual report is outJul 15, 2021

SERA-SCANDIA A/S has published its annual report for 2020. Revenue came to DKK 3,683,000, and the net result was DKK -16,558,000.

About SERA-SCANDIA A/S

SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.

Source: annual report 2025, Danish Business Authority